Efficacy and Safety of Lebrikizumab in Combination With Topical Corticosteroids in Adolescents and Adults With Moderate-to-Severe Atopic DermatitisEric L. Simpson, Brad Glick, April W. Armstrong et al.|JAMA Dermatology|2023Cited by 148
Comparison of risankizumab and apremilast for the treatment of adults with moderate plaque psoriasis eligible for systemic therapy: results from a randomized, open-label, assessor-blinded phase IV study (IMMpulse)Linda Stein Gold, Kim Papp, Jerry Bagel et al.|British Journal of Dermatology|2023Cited by 22